MRD / Regn No. : THBC\23-24\01283 Date : 15/06/2026
Patient Name : Rakhi Nagpal Age & Gender : 46 Yrs. / Female
Contact No. : 9619582385 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Subjective : T2DM - 10YRS,HYPOTHYROIDISM- 10 YRS,HBA1C 7.9% TO 8.4% FROM AUGUST 2025
Objective : FEB-2026 REPORTS,HB-13.1/ HBA1C-7.50%,FBS-103.1,TSH-3.1484,CR-1.00,ALT-30/ AST-21.9,TC-144/ TG-90.8/ LDL-81.34/ HDL-44.5,CA-9.00
Plan : CONSIDER SEMAGLUTIDE ONCE MORE AFFORDABLE,INJ SEMAGLUTIDE / ONCE WEEKLY  
S# Generic (Trade) Name Route Dosage Usage Duration
1 THYRONORM 75 MCG ORAL 1-0-0 BBF / 2 TABS EVERY SUNDAY
4 MTHS
2 DRISE 60,000 ORAL ONCE IN 15 DAYS ANYTIME OF DAY
4 MTHS
3 ZORYL 1 MG ORAL 1-0-1 BBF / BD
4 MTHS
4 ME 12 OD ORAL 0-1-0 ALT DAY
4 MTHS
5 UDAPA S 10/100 MG ORAL 1-0-0 ABF
4 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 18/Mar/2026
Tests Suggested For Next Visit : FBS / PPBS / HBA1C / TSH > 4 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: